\[1\]Durn J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr \[J\]. Am J Respir Crit Care Med, 2001, 163(3):685-689.［2］Punjabi NM. The epidemiology of adult obstructive sleep apnea \[J\]. Proc Am Thorac Soc, 2008, 5 (2):136-143.［3］Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension \[J\]. N Engl J Med, 2000, 342(19):1378-1384.［4］O′Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study\[J\]. Am J Respir Crit Care Med, 2009, 179(12):1159-1164.［5］Fenech M. Cytokinesisblock micronucleus cytome assay \[J\]. Nat Protoc, 2007, 2(5): 1085-1104.［6］中华医学会呼吸病学分会睡眠呼吸障碍学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南:2011年修订版\[J\]. 中华结核和呼吸杂志，2012，35(1)：9-12.［7］中国高血压防治指南修订委员会.中国高血压防治指南2010\[J\].中华高血压杂志，2011,19（8）:701-743.［8］Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale \[J\]. Sleep, 1991, 14 (6): 540-545.［9］Svatikova A, Wolk R, Lerman LO, et al. Oxidative stress in obstructive sleep apnoea\[J\]. Eur Heart J, 2005, 26(22):2435-2439.［10］Yamauchi M, Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications \[J\]. Antioxid Redox Signal, 2008, 10(4):755-768.［11］Moller P, Loft S, Lundby C, et al. Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans \[J\]. FASEB J, 2001, 15(7): 1181-1186.［12］Konstantina K, Niki M, Konstantinos C, et al. DNA damage and repair capacity in lymphocytes from obstructive sleep apnea patients\[J\]. Environ Mol Mutagen, 2007, 48(9):722-727.［13］谢婧，张学良，任茜,等. 阻塞性睡眠呼吸暂停低通气综合征患者外周血淋巴细胞的DNA损伤及意义\[J\].临床荟萃，2010,25(2):108-111.［14］Barbé F, DuránCantolla J, SánchezdelaTorre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial \[J\]. JAMA, 2012, 307(20):2161-2168.［15］Jelic S, Padeletti M, Kawut SM,et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea \[J\]. Circulation, 2008, 117 (17): 2270-2278.［16］Karamanlｌ H, Ozol D, Ugur KS, et al. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients \[J\]. Sleep Breath, 2014, 18(2):251-256.［17］JuradoGamez B, GomezChaparro JL, MuozCalero M, et al. Serum proteomic changes in adults with obstructive sleep apnoea \[J\]. J Sleep Res, 2012, 21(2):139-146.［18］Jordan W, Cohrs S, Degner D, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome \[J\] . J Neural Transm, 2006, 113(2):239-254.［19］Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome \[J\]. Chest, 2008, 134(4):686-692.［20］BarbF, DurnCantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea \[J\]. Am J Respir Crit Care Med, 2010, 181(7):718-726.［21］Hedner J, Grote L. The link between sleep apnea and cardiovascular disease: time to target the nonsleepy sleep apneics? \[J\]. Am J Respir Crit Care Med, 2001, 163 (1):5-6.［22］Marin JM, Carrizo SJ, Vicente E, et al. Longterm cardiovascular outcomes in men with obstructive sleep apnoea hypopnoea with or without treatment with continuous positive airway pressure: an observational study \[J\]. Lancet, 2005,365 (9464):1046-1053.［23］Lesske J, Fletcher EC, Bao G, et al. Hypertension caused by chronic intermittent hypoxia influence of chemoreceptors and sympathetic nervous system \[J\]. J Hypertens, 1997, 15 (12 Pt 2):1593-1603.［24］Cooper VL, Elliott MW, Pearson SB, et al. Daytime variability of baroreflex function in patients with obstructive sleep apnoea: implications for hypertension \[J\]. Exp Physiol, 2007, 92 (2):391-398.［25］Hedner J, Darpo B, Ejnell H, et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications \[J\]. Eur Respir J, 1995, 8 (2):222-229.［26］Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea \[J\]. Circulation, 1999, 100 (23): 2332-2335.［27］Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial \[J\]. Lancet, 2002, 359 (9302):204-210.
2014, Vol. 24 
